共 50 条
- [5] Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 47 - 55
- [7] Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus AMERICAN JOURNAL OF MEDICINE, 2003, 115 : 24 - 28